The prevalence remained significantly higher for this group compared with the other groups after adjustment, resulting in an adjusted OR of 61.4 for the comparison of any ILD for ever smokers with anti-PAD3/4XR compared with never smokers without the antibody (p = 0.001). The gene discussed is PADI3; the disease is interstitial lung disease.